These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 19592617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R, Taher J, Baker C, Adeli K, Su Q.
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T, Park EJ, Je J, Jeong K, Yun SP, Kim HJ, Kim H, Park SW.
    Int J Mol Sci; 2021 May 24; 22(11):. PubMed ID: 34073834
    [Abstract] [Full Text] [Related]

  • 8. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM, Mulvihill EE, Burke AC, Sutherland BG, Telford DE, Chhoker SS, Sawyez CG, Drangova M, Adams AC, Kharitonenkov A, Pin CL, Huff MW.
    Endocrinology; 2015 Jun 24; 156(6):2087-102. PubMed ID: 25774553
    [Abstract] [Full Text] [Related]

  • 9. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
    Lian J, Quiroga AD, Li L, Lehner R.
    Circ Res; 2012 Sep 28; 111(8):982-90. PubMed ID: 22872154
    [Abstract] [Full Text] [Related]

  • 10. Cholesterol-induced hepatic inflammation does not underlie the predisposition to insulin resistance in dyslipidemic female LDL receptor knockout mice.
    Gruben N, Funke A, Kloosterhuis NJ, Schreurs M, Sheedfar F, Havinga R, Houten SM, Shiri-Sverdlov R, van de Sluis B, Kuivenhoven JA, Koonen DP, Hofker MH.
    J Diabetes Res; 2015 Sep 28; 2015():956854. PubMed ID: 25815343
    [Abstract] [Full Text] [Related]

  • 11. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.
    Han S, Liang CP, Westerterp M, Senokuchi T, Welch CL, Wang Q, Matsumoto M, Accili D, Tall AR.
    J Clin Invest; 2009 Apr 28; 119(4):1029-41. PubMed ID: 19273907
    [Abstract] [Full Text] [Related]

  • 12. PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins.
    Lindén D, Alsterholm M, Wennbo H, Oscarsson J.
    J Lipid Res; 2001 Nov 28; 42(11):1831-40. PubMed ID: 11714852
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ, Baker C, Naples M, Samsoondar J, Zhang R, Qiu W, Sacco J, Adeli K.
    Atherosclerosis; 2013 May 28; 228(1):98-109. PubMed ID: 23466071
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA, Burke AC, Chhoker SS, Telford DE, Sutherland BG, Edwards JY, Sawyez CG, Tirona RG, Yin H, Pickering JG, Huff MW.
    Arterioscler Thromb Vasc Biol; 2014 Jan 28; 34(1):52-60. PubMed ID: 24158519
    [Abstract] [Full Text] [Related]

  • 15. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α.
    Lucero D, Miksztowicz V, Macri V, López GH, Friedman S, Berg G, Zago V, Schreier L.
    Clin Investig Arterioscler; 2015 Jan 28; 27(4):167-74. PubMed ID: 25796423
    [Abstract] [Full Text] [Related]

  • 16. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
    Mangaloglu L, Cheung RC, Van Iderstine SC, Taghibiglou C, Pontrelli L, Adeli K.
    Metabolism; 2002 Apr 28; 51(4):409-18. PubMed ID: 11912545
    [Abstract] [Full Text] [Related]

  • 17. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.
    Tu P, Bhasin S, Hruz PW, Herbst KL, Castellani LW, Hua N, Hamilton JA, Guo W.
    Diabetes; 2009 Aug 28; 58(8):1739-48. PubMed ID: 19509018
    [Abstract] [Full Text] [Related]

  • 18. Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr-/- Mice.
    Burke AC, Telford DE, Edwards JY, Sutherland BG, Sawyez CG, Huff MW.
    Mol Nutr Food Res; 2019 Mar 28; 63(6):e1800833. PubMed ID: 30578663
    [Abstract] [Full Text] [Related]

  • 19. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr-/- Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid.
    Samsoondar JP, Burke AC, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Pinkosky SL, Newton RS, Huff MW.
    Arterioscler Thromb Vasc Biol; 2017 Apr 28; 37(4):647-656. PubMed ID: 28153881
    [Abstract] [Full Text] [Related]

  • 20. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.
    Obesity (Silver Spring); 2010 Apr 28; 18(4):780-7. PubMed ID: 19798065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.